13
Participants
Start Date
October 31, 2002
Primary Completion Date
March 31, 2011
Study Completion Date
December 31, 2016
r-metHuLeptin
recombinant human leptin
placebo
placebo (no active drug)
Beth Israel Deaconess Medical Center, Boston
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
National Center for Research Resources (NCRR)
NIH
Amgen
INDUSTRY
Beth Israel Deaconess Medical Center
OTHER